Visbion receives Innovate UK Smart Award for synthetic biology
Wed, 08/07/2015 - 10:00
Cambridge Research Biochemicals continues to enjoy Preferred Supplier Status with the Medical Research Council
Wed, 01/07/2015 - 09:00
Cambridge Research Biochemicals (CRB) will continue to supply The Medical Research Council (MRC) with custom-synthesised peptides and bespoke polyclonal and monoclonal antibodies for a further 12 months as a valued preferred supplier under a new pricing agreement.
Wed, 01/07/2015 - 08:00
Domainex Ltd, a private drug discovery service company, today announces that it is launching an integrated bioassay service platform, BioassayBuilder.
Thu, 25/06/2015 - 11:30
Plans to create a £10bn ‘megafund’ that would make it easier for pharmaceutical companies in London and across the country.
Tue, 23/06/2015 - 07:00
BioGateway, the new life science network for Kent is launched today at an event being held at Discovery Park in Sandwich. BioGateway aims to become the most complete life science network in Europe serving as the gateway between the UK and the rest of Europe.
Mon, 11/05/2015 - 12:30
Minneapolis, USA and Reinach, Switzerland, 11 May 2015 / Sciad Newswire / – Evolva and Cargill have agreed to begin the engineering phase for converting an existing Cargill manufacturing facility to produce next-generation stevia sweeteners.
Domainex announces the grant of US and European patents for its lead programme, targeting IKK epsilon and TBK1 for the Treatment of diseases such as COPD and Psoriasis
Mon, 11/05/2015 - 09:00
Cambridge, UK, 11th May 2015 / Sciad Newswire / Domainex Ltd. today announced that The US and European
Wed, 22/04/2015 - 14:30
Platform Delivers High-Quality Genes Using 10,000-well Silicon-Based Proprietary Platform Amyris to Become Early Adopter of Technology Platform
Domainex prepares for expansion as it announces the appointment of Barry Knight as Chief Financial Officer and Company Secretary, and Thomas Mander as Chief Operating Officer
Wed, 08/04/2015 - 09:00
Cambridge, UK, 8th April 2015 / Sciad Newswire / Barry Knight is a Chartered Accountant and brings extensive financial expertise to Domainex, having been an exec
Biotech and Money Congress joined by BioMedical Catalyst - Delegates to meet the awards body at Congress
Tue, 27/01/2015 - 09:00
London, UK, 27th January 2015 / Sciad Newswire / Biotech and Money London, 3-4 February 2015: Biotech and Money, t